Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Intimation for receipt of Notice for non-compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations )
GKSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gujarat Kidney and Super Speciality Limited informed the exchanges that it received notices from both NSE and BSE on 17 March 2026 for failing to submit its financial results for the quarter ended 30 September 2025 within the timeline prescribed under Regulation 33 of the SEBI Listing Regulations. Each exchange has levied a fine of Rs. 3,30,400 (including GST), taking the total penalty exposure to Rs. 6,60,800. The company has stated that the fine has no material impact on its financial position or operations. The matter will be placed before the Board shortly, after which the company will decide its next course of action and inform the exchanges.
The penalty is small in financial terms and the company has confirmed no operational or financial impact, but the episode flags a governance/compliance lapse in timely financial reporting, which investors may view as a minor negative signal. Watch for the Board's response and whether the company pays, contests, or seeks waiver of the fine.